<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03408353</url>
  </required_header>
  <id_info>
    <org_study_id>PA17-0584</org_study_id>
    <secondary_id>NCI-2020-07361</secondary_id>
    <secondary_id>PA17-0584</secondary_id>
    <nct_id>NCT03408353</nct_id>
  </id_info>
  <brief_title>Mammography, Early Detection Biomarkers, Risk Assessment, and Imaging Technologies, MERIT Study</brief_title>
  <official_title>MERIT (Mammography, Early Detection Biomarkers, Risk Assessment, and Imaging Technologies) Cohort</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>M.D. Anderson Cancer Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Cancer Institute (NCI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>M.D. Anderson Cancer Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study collects mammogram images, blood samples, and clinical information from women&#xD;
      undergoing routine screening mammograms. Creating a bank of blood samples and a database of&#xD;
      clinical and risk information may be used in future research related to breast cancer, other&#xD;
      cancers, and women's health.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      PRIMARY OBJECTIVES:&#xD;
&#xD;
      I. To establish a longitudinal cohort (n=10,000) of women who undergo mammography screening&#xD;
      with follow-up for at least five years for each study participant or until breast cancer&#xD;
      diagnosis.&#xD;
&#xD;
      II. To create a repository of blood specimens from the cohort to use for biomarker discovery&#xD;
      and validation.&#xD;
&#xD;
      III. To create a comprehensive integrated database of imaging, clinical data, health&#xD;
      measurements, and questionnaire data on the study participants.&#xD;
&#xD;
      OUTLINE:&#xD;
&#xD;
      Participants complete questionnaires over 15-25 minutes about personal and family history of&#xD;
      cancer, health status, breast cancer risk factors, diet, weight gain, and physical activity,&#xD;
      and undergo collection of blood samples at baseline and then annually for 5 years.&#xD;
      Participants also undergo standard of care mammography at baseline and then annually for 5&#xD;
      years.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 15, 2017</start_date>
  <completion_date type="Anticipated">October 30, 2023</completion_date>
  <primary_completion_date type="Anticipated">October 30, 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Creation of a repository of blood specimens and database of imaging, clinical data, health measurements, and questionnaire data</measure>
    <time_frame>5 years</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">10000</enrollment>
  <condition>Breast Carcinoma</condition>
  <arm_group>
    <arm_group_label>Observational (mammography, questionnaires, blood collection)</arm_group_label>
    <description>Participants complete questionnaires over 15-25 minutes about personal and family history of cancer, health status, breast cancer risk factors, diet, weight gain, and physical activity, and undergo collection of blood samples at baseline and then annually for 5 years. Participants also undergo standard of care mammography at baseline and then annually for 5 years.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Biospecimen Collection</intervention_name>
    <description>Undergo collection of blood samples</description>
    <arm_group_label>Observational (mammography, questionnaires, blood collection)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Mammography</intervention_name>
    <description>Undergo standard of care mammography</description>
    <arm_group_label>Observational (mammography, questionnaires, blood collection)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Questionnaire Administration</intervention_name>
    <description>Complete questionnaires</description>
    <arm_group_label>Observational (mammography, questionnaires, blood collection)</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Participants receiving screening mammograms at MD Anderson site&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Willingness to participate in the study and ability to provide informed consent&#xD;
&#xD;
          -  Willingness to complete a questionnaire and to provide a blood sample at the initial&#xD;
             visit and at follow up annual visits&#xD;
&#xD;
          -  Undergoing a screening mammogram at participating sites. Subjects undergoing routine&#xD;
             annual diagnostic mammograms are also eligible at the MD Anderson site&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Current or recent (within the prior 6 months) history of breast feeding&#xD;
&#xD;
          -  Personal history of breast cancer (ductal breast carcinoma in situ [DCIS] or invasive&#xD;
             breast cancer)&#xD;
&#xD;
          -  Treatment of any other type of cancer within the past 5 years excluding in situ&#xD;
             cervical and non-melanoma skin cancer&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jessica W Leung</last_name>
    <role>Principal Investigator</role>
    <affiliation>M.D. Anderson Cancer Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jessica Leung</last_name>
    <phone>713-745-4555</phone>
    <email>jwleung@mdanderson.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>M D Anderson Cancer Center</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jessica W. Leung</last_name>
      <phone>713-745-4555</phone>
      <email>jwleung@mdanderson.org</email>
    </contact>
    <investigator>
      <last_name>Jessica W. Leung</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.mdanderson.org</url>
    <description>The University of Texas MD Anderson Cancer Center Official Website</description>
  </link>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>December 11, 2017</study_first_submitted>
  <study_first_submitted_qc>January 22, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">January 24, 2018</study_first_posted>
  <last_update_submitted>March 31, 2021</last_update_submitted>
  <last_update_submitted_qc>March 31, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

